HARVARD BIOSCIENCE INC — Director's Dealing 2019

Aug 1, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2019-08-01

Reporting Person: LOY BERTRAND (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-08-01	Common Stock	A	6600	$0.00	Acquired	191550	Direct

Footnotes

F1: Represents a deferred stock award of 6,600 restricted stock units which vest quarterly in equal installments on September 30, 2019 and December 31, 2019. This retainer award was granted in lieu and satisfaction of the annual cash retainer compensation to be earned by the director for his service as the Lead Independent Director of the Issuer's Board of Directors that the reporting person was appointed to following the 2019 Annual Meeting of Stockholders. The number of shares of common stock subject to such retainer award is equal to the amount of cash that would have been received had the applicable retainer all been paid in cash, divided by the average daily closing market price of the Issuer's common stock for the month of May, rounded to the nearest 100 shares.

F2: Includes (a) a deferred stock award of 6,600 restricted stock units which vest quarterly in equal installments on September 30, 2019 and December 31, 2019 as described in footnote 1 above; (b) a deferred stock award of 35,100 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 16, 2019, immediately prior to the commencement of such meeting, and (ii) May 23, 2020; (c) a deferred stock award of 7,000 restricted stock units which vest quarterly in equal installments on September 30, 2019 and December 31, 2019; and (d) 142,850 shares of common stock held by the Reporting Person.